ENOB - Enochian Biosciences Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
8.20
-0.35 (-4.09%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close8.55
Open8.20
Bid2.00 x 1000
Ask9.75 x 800
Day's Range8.00 - 8.50
52 Week Range3.32 - 9.50
Volume68,926
Avg. Volume36,286
Market Cap296.626M
Beta (3Y Monthly)0.49
PE Ratio (TTM)N/A
EPS (TTM)-0.41
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    PR Newswire5 days ago

    OTC Markets Group Announces Quarterly Index Performance and Rebalancing

    NEW YORK , Jan. 16, 2018 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the fourth quarter 2018 performance ...

  • GlobeNewswire14 days ago

    Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

    Enochian Biosciences, Inc. (“Enochian”) a biopharmaceutical company focused on the development and commercialization of novel therapies for HIV/AIDS and oncology, announced today that the Company’s new Executive Vice-Chair, Dr. Mark Dybul will be taking over the leadership of the Company following the departure of Eric Leire as Chief Executive Officer. Dr. Dybul had previously served as Chair of the Company’s Scientific Advisory Board beginning in August of 2017, and as a director since February of 2018.

  • How Much Of Enochian Biosciences Inc. (NASDAQ:ENOB) Do Insiders Own?
    Simply Wall St.17 days ago

    How Much Of Enochian Biosciences Inc. (NASDAQ:ENOB) Do Insiders Own?

    A look at the shareholders of Enochian Biosciences Inc. (NASDAQ:ENOB) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge Read More...

  • GlobeNewswire2 months ago

    Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”

    – Appoints former President of GSK Global Vaccine business, Luc Debruyne, to Board of Directors – – Advances ENO-1001 for HIV by entering into research collaboration.

  • GlobeNewswire2 months ago

    Enochian Biosciences to Present at Biotech Showcase 2019

    LOS ANGELES, Dec. 03, 2018 -- Enochian Biosciences, Inc. (“Enochian”) (OTCQB: ENOB), a biopharmaceutical company developing potentially curative and preventative gene-modified.